Doctors & Dentists Urged To Learn On The Net

Belfast company launches video based e-learning site for healthcare professionals in partnership with leading UK professional bodies. An innovative video based website that can help doctors, dentists and pharmacists polish up on their professional skills whenever and wherever they want has been launched by Northern Ireland based company, StreamOn. Edcast Medical provides expert training from leading medical professional bodies: the Royal College of Obstetricians and Gynaecologists in London; the Northern Ireland Medical and Dental Training Agency; the Northern Ireland Centre for Postgraduate Pharmaceutical Education and Training and iPath, a QUB spinout company from the School of Pathology. Courses in general practice, dentistry, pharmacy, obstetrics and gynaecology and pathology are available direct to the user's PC from £20, representing a significant time and cost saving on attendance at lectures & seminars.

Speaking at a special launch reception held in Parliament Buildings, Stormont, Northern Ireland Economy Minister, Nigel Dodds said: "Edcast Medical is a great example of how local creative digital talent can be applied to break new ground in global e-learning platforms. I hope it encourages other businesses here to see the commercial potential of the internet and paves the way for further innovation in this area."

Other e-learning websites exist but none can match Edcast Medical for the range and quality of professionally developed courses explained Mark McCann of StreamOn. "Each addresses a training issue in depth, using a range of learning tools including video lectures with PowerPoint, video based patient/practitioner scenarios, equipment and procedure video demonstrations, knowledge testing, supporting downloadable documentation, and discussion forums. Medical professionals are required to undertake high level continuing professional development as a mandatory requirement of their membership to professional bodies. Edcast Medical is the first provider to offer the ability for professional bodies to broker their knowledge online in such a video rich format. It eliminates the dependence on traditional training events which is a particular advantage for bodies with dispersed memberships. The need for time-consuming travel is minimised, as is cost for the trainee and their employer. Thanks to the benefits of broadband technology" continued Mark, "there is the added convenience to the professional of being able to update their knowledge and skills whenever and wherever they want."

Also speaking at the launch, Professor James Dornan, Immediate Past Senior President of the Royal College of Obstetricians and Gynaecologists said: "EdCast Medical has provided a new, dynamic and interactive way of providing learning opportunities for our dispersed membership, allowing us to reach them directly and eradicating the time and expense needed to travel to our training facility in London."

Discussions are also already underway between StreamOn and other professional bodies and colleges in the UK and further afield to offer further specialist training courses online.

Edcast Medical is 1 of 6 government-backed broadband content initiatives showcasing Northern Ireland's digital creative talent to the world under the www.crea8ivity.com banner and has received financial backing under the Department of Enterprise, Trade & Investment's Broadband Content Initiative.

For further information, please visit:
http://www.edcastmedical.com

About StreamOn
EdCast Medical has been developed by StreamOn.net Ltd., a spin-out company from The School of Computer Science at Queen's University Belfast. Since the company was established in 2000 it has delivered complex broadband multimedia, web-based Content Management and e-Learning solutions to companies such as Hewlett Packard, Panasonic, a number of government agencies and public sector bodies.

EdCast Medical is a web platform from StreamOn that enables medical professionals to access video based medical training courses. Each of these is designed by professional bodies and delivered by highly respected experts. The site is being launched with 23 courses available in the disciplines of general practice, dentistry, pharmacy, obstetrics and gynaecology, and pathology.

Most Popular Now

Pfizer to provide U.S. government with 10 million …

Pfizer Inc. (NYSE: PFE) today announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candid...

GSK and Vir Biotechnology announce United States g…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) announced US government contracts totalling approximately $1 billion[1] (USD) to purchase so...

Primary endpoint met in COMET-TAIL Phase III trial…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Vir) (Nasdaq: VIR) announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase...

Two billion doses of AstraZeneca’s COVID-19 vaccin…

AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the l...

Merck and Ridgeback's molnupiravir, an oral COVID-…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the United Kingdom Medicines and Healthcare products Re...

Johnson & Johnson COVID-19 vaccine named one o…

The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021. The vaccine, for which Johnson & ...

New target for COVID-19 vaccines identified

Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, c...

Repurposing a familiar drug for COVID-19

For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines. Every day...

Safety concerns raised for neuroblastoma candidate…

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Th...

Pfizer and BioNTech receive expanded U.S. FDA emer…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a ...

'Dancing molecules' successfully repair severe spi…

Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal ...

A target for potential cancer drugs may, in fact, …

In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyro...